A Really Long Strange Trip

 
Sponsored by
 

Email To A Friend

Please fill in the following information and we'll email this link.

Separate multiple addresses with commas

 

To thwart criticism about the legitimacy of the work, psychedelic researchers have focused on developing sound protocols. Unlike earlier research, the current studies are double-blind with a control group—two staples of sound science that guard against researcher bias in the interpretation of results.

And along with his latest study, Griffith has published a series of guidelines intended to protect volunteers and ensure the integrity of data. Those guidelines describe how to eliminate subjects with a family history of mental illness and advise that the clinician administering the substance take a full day to establish rapport with a given volunteer so that they can guide them through any difficult moments the experience might cause.

It's a far cry from the Leary era, which was plagued by too much media hype and not enough scientific rigor, but the approach is starting to pay off. As Harvard, Johns Hopkins, UCLA and others open their doors to psilocybin, LSD and MDMA (Ecstasy), scientists there are beginning to examine the therapeutic value of these long-maligned molecules. Already, Psilocybin and MDMA have shown promise in treating a range of conditions, including Obsessive Compulsive Spectrum Disorders (OCSD), anxiety in terminally ill cancer patients, and Post-Traumatic Stress Disorder (PTSD). Harvard scientists are at work on a protocol to study the benefits of LSD in treating cluster headaches—a project that began when an online community of patients who were self-medicating with the drug contacted researchers.

To be sure, these early trials are small, consisting of fewer than two dozen patients each. Larger-scale investigations will require more funding and wider acceptance, but proponents are optimistic. "I think a lot of basic scientists will start to migrate back to this type of work," says Nichols. "We'll start to see some real progress if we don't burn any bridges and we keep ourselves squeaky clean."

© 2008

 
Discuss
Member Comments
  • Posted By: banwa2121 @ 07/21/2008 4:42:16 PM

    Comment: I have been using mushrooms for about 5-6 years for cluster headaches and they have been life-saving. When I stay on schedule (every 6 months) I can go 20 months without getting a cycle of CHs. If I forget a dose or under dose (no heightened visual, auditory or sensory perception) the cycle hits me twice a year. I have no idea why mushrooms help, but I'm glad I have them!

  • Posted By: banwa2121 @ 07/21/2008 4:41:58 PM

    Comment: I have been using mushrooms for about 5-6 years for cluster headaches and they have been life-saving. When I stay on schedule (every 6 months) I can go 20 months without getting a cycle of CHs. If I forget a dose or under dose (no heightened visual, auditory or sensory perception) the cycle hits me twice a year. I have no idea why mushrooms help, but I'm glad I have them!
    mageable.

  • Posted By: Sinibaldi @ 07/07/2008 10:59:29 AM

    Comment: Le sourire persuasif de la modernité.

    Ici il y a une
    grande couleur qui
    me prend doucement
    dans l'aube de
    mes rêves, comme
    une frele harmonie
    qui rappelle la jeunesse;
    et quand le vent
    disparaît en donnant
    cette poésie, là-bas,
    dans mon coeur,
    un sourire corporel
    invente la tempête.

    Francesco Sinibaldi

Sponsored by
 
 
 
The Peek
 
 
STRATEGIES

Isn't it ironic: Xerox is hoping it can profit by teaching companies how to reduce their printing.

Sponsored by
 
 
 
 
NATIONAL SECURITY
Sponsored by
 
 
 
loadingLoading Menu